Regeneron Pharmaceuticals Business Operations Contracts & Agreements

34 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Amended and Restated License and Collaboration Agreement by and between the Registrant and Aventis Pharmaceuticals Inc., dated May 1, 2013
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Modification P00007 to Supply Agreement, dated as of July 29, 2022, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00003 to Supply Agreement, dated as of July 8, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00002 to Supply Agreement, dated as of June 17, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00001 to Supply Agreement, dated as of March 9, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Fifth Amendment to Amended and Restated License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amended and Restated Immuno-Oncology License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification P00006 to Supply Agreement, dated as of February 24, 2022, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
First Amendment to Immuno-oncology License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Fourth Amendment to Amended and Restated License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00005 to Supply Agreement, dated as of September 14, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification P00004 to Supply Agreement, dated as of July 26, 2021, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and the U.S. Army Contracting Command, New...
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Third Amendment to Amended and Restated License and Collaboration Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant, Sanofi...
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Form of Co-Co Collaboration Agreement (Exhibit B to Master Agreement contained in Exhibit 10.4)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Immuno-oncology Discovery and Development Agreement, executed on January 2, 2019 and effective as of December 31, 2018, by and between the Registrant and...
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
AMENDMENT NO. 2 TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
AMENDMENT NO. 1 TO AMENDED AND RESTATED DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
AMENDED AND RESTATED COLLABORATION AGREEMENT By and Between SANOFI-AVENTIS US, LLC and REGENERON PHARMACEUTICALS, INC. Dated as of February 23, 2015 TABLE OF CONTENTS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
NON-EXCLUSIVE LICENSE AND SETTLEMENT AGREEMENT
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
AMENDED AND RESTATED NON-EXCLUSIVE LICENSE AND SETTLEMENT AGREEMENT
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
AMENDED AND RESTATEDDISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT By and Between AVENTIS PHARMACEUTICALSINC. and REGENERON PHARMACEUTICALS,INC. Dated as of November 10, 2009...
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
TRAP -2 TERMINATION AGREEMENT By and Between NOVARTIS PHARMA AG NOVARTIS PHARMACEUTICALS CORPORATION AND REGENERON PHARMACEUTICALS, INC. Dated as of June 8, 2009
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
IL-1 ANTIBODY TERMINATION AGREEMENT By and Between NOVARTIS PHARMA AG NOVARTIS PHARMACEUTICALS CORPORATION AND REGENERON PHARMACEUTICALS, INC. Dated as of June 8, 2009
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2009
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
EX-10.1: LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
EX-10.13.4: AMENDMENT NO. 4 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
EX-10.13.3: AMENDMENT NO. 3 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
AMENDMENT NO. 1 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
SECOND AMENDMENT TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
COLLABORATION, LICENSE AND OPTION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
EX-10.22: FOCUSED COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002